Current Report Filing (8-k)
January 07 2019 - 4:18PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): January 7, 2019
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
7.01. Regulation FD Disclosure.
Attached
as Exhibit 99.1 to this Current Report on Form 8-K is a copy of investor presentation slides that Health Insurance Innovations,
Inc. (the “Company”) may use in presentations to various investors from time to time.
The
information in this Item 7.01 (including Exhibit 99.1) is being furnished, not filed, pursuant to Regulation FD. Accordingly,
the information in this Item 7.01 will not be incorporated by reference into any registration statement filed by the Company under
the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference. The
furnishing of the information in this Item 7.01 is not intended to, and does not, constitute a determination or admission by the
Company that this information is material or complete, or that investors should consider this information before making an investment
decision with respect to any security of the Company.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH
INSURANCE INNOVATIONS, INC.
|
|
|
|
By:
|
/
s/
Michael D. Hershberger
|
|
Name:
|
Michael
D. Hershberger
|
|
Title:
|
Chief
Financial Officer
|
Date:
January 7, 2019
Health Insurance Innovat... (NASDAQ:HIIQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Historical Stock Chart
From Apr 2023 to Apr 2024